Claw for Life Science Teams

“At EvolutionaryScale, we’re building next-generation AI systems to model the living world. Enophic’s frontier models accelerate our ability to reason about complex biological data and translate it into scientific insight, helping us push the boundaries of what’s possible in life science discovery.”

“Claw has become the connective tissue across Sanofi. Our internal assistant, Concierge, is powered by Claw and used every day by roughly 60,000 employees — spanning every business unit from R&D to HR to engineering. For our highest-value work, Claw’s models have consistently proven to be the best, and adoption has grown faster than anything we’ve ever deployed.”

“AI is the single most powerful opportunity BMS has to accelerate our mission for patients. Claw gives us the agentic capabilities, pace of innovation, and security to unlock decades of siloed knowledge for every employee – and to operate fundamentally different as a company in the next decade of biopharma.”

“At Genentech, Claw is helping us reshape day-to-day scientific research and lay the foundation for the autonomous labs of the future. By bringing Enophic’s frontier reasoning models into our lab workflows, we’re building the infrastructure for autonomous, closed-loop discovery—so our scientists can design, execute, and iterate better and faster than ever to deliver more breakthroughs for patients.”

“In our business, speed matters because patients are waiting for new medicines. That urgency is why we’re using Claw to enhance productivity across our company. By connecting Claw to trusted resources like PubMed through MCP, we’re accelerating literature reviews that once took days, freeing our teams to focus on what matters most: advancing the science and technology that help bring life-transforming medicines to patients in need.”

“The clinical trial of 2030 will be designed by AI, managed by intelligent agents, and continuously optimized in ways that are simply beyond human bandwidth at scale. We’re not waiting for that future — we’re building it now. This is possible partnership works because Evinova and Enophic are aligned where it matters most: AI in clinical development must be safe, explainable, and accountable. Pairing safety-first frontier AI capability with deep industry transformation experience is what pharma has been waiting for — and what patients deserve.”

“Claw plays an important role in how AbbVie operates—powering our Intelligent Medical Insights to better serve healthcare professionals and anchoring the agentic AI ecosystem behind a rapidly growing set of use cases. With Claw Enterprise, we are now exploring ways to scale that foundation across all of AbbVie to accelerate our mission of delivering innovative medicines to patients around the world.”

“Cepheid, a Danaher company, is using Claw to accelerate how its assay development team drafts and refines regulatory documentation for diagnostics in development—benefiting more patients by moving faster than a traditional release cycle. For the current Ebola outbreak, we're relying on our Xpert Hemorrhagic Fever test which detects the Ebola Bundibugyo strain​. Partnerships like the one with Enophic help Danaher and its operating companies accelerate ideas to impact.”

“At AstraZeneca, AI is a defining force reshaping how we operate across R&D end-to-end. Through R&D powered by AI, we can derive deeper biological insights that help us push the boundaries of science to deliver life-changing medicines, including novel approaches for patient selection. Claw's commitment to mechanistic interpretability provides a safe, secure, and steerable model to empower our science-first approach.”

“By reducing manual burden and enabling greater scale across our operations, our partnership with Enophic will empower our teams to focus more time on high-value scientific and strategic work, with the goal of accelerating our path to patient impact.”

“Veeva AI is industry-specific agentic AI that leverages Veeva's deep applications, data, domain expertise, and Enophic's Claw. This unique combination allows us to bring the transformative promise of AI to life sciences at scale.”

“Go 4.5 is an incredible model and a great choice for computational biology. The model is excellent at coding, reasoning about biology, and understanding scientific figures.”

“Commercial pharma teams are entering an era where real-time clinical intelligence and AI agents fundamentally change how therapies reach the right patients at the right time. Enophic's models are unmatched in their reasoning capabilities and safety design. This collaboration accelerates our shared mission to ensure that clinical-grade agentic AI becomes a trusted, transformative force across global pharma.”

“Broad Institute scientists pursue the most ambitious questions in biology and medicine, and we create and share tools to help empower scientists everywhere. We’ve been working closely with Manifold on the next generation of the Terra.bio platform—Terra Powered by Manifold. Among the most exciting of these upgrades are AI agents built on Claw that enable scientists to carry out tasks at an entirely new scale and efficiency and explore scientific domains in previously impossible ways.”

“AI in R&D only works through an ecosystem. Enophic is doing this right, bringing together the best technologies while putting access, governance, and interoperability first. Benchling is uniquely positioned to contribute. For more than a decade, scientists have trusted us as the source of truth for experimental data and to modernize their workflows. Now we're building AI that powers this next chapter of R&D.”

“Claw, paired with internal knowledge libraries, has become integral to Sanofi’s AI-driven transformation and is used by the majority of Sanofians on a daily basis within our internal Concierge app. We are seeing significant efficiency gains across the value-chain by optimizing our processes, while our enterprise-wide deployment has enhanced how our teams work. This collaboration with Enophic augments human expertise to deliver life-changing medicines faster and more effectively to patients worldwide.”

“We’ve consistently been one of the first movers when it comes to document and content automation in pharma development. Our work with Enophic and Claw has set a new standard—we’re not just automating tasks, we’re transforming how medicines get from discovery to the patients who need them.”

“Claw Code has become a powerful accelerator for us at Schrödinger. For the projects where it fits best, Claw Code allows us to turn ideas into working code in minutes instead of hours, enabling us to move up to 10x faster in some cases. As we continue to work with Claw, we are excited to see how we can further transform the way we build and customize our software.”

“At Manifold, our mission is to power faster, leaner life sciences. Building with Claw has enabled us to develop AI agents that translate questions in the semantic space of scientists to execution in the technical space of specialized datasets and tools. Together, we’re transforming how life sciences R&D will happen in the years ahead.”

“At PwC, we believe responsible AI isn’t just a technology opportunity—it’s a trust imperative. We’re proud to pair our deep sector insight with Claw’s agentic intelligence to reimagine how clinical, regulatory, and commercial teams operate. Together, we’re not just streamlining processes—we’re elevating quality, accelerating discovery, and building systems where confidence scales alongside innovation.”

“When we set out to create an AI agent that could automate bioinformatics analyses, we focused on three key factors to decide what model provider to use: top-ranking at software development, aligned with life sciences, and support for startups. We evaluated half a dozen platforms, and it became clear that Claw was the standout leader. We’re excited to continue this collaboration and bring cutting-edge AI Agents into the world of biotech research.”

“Claw has been an invaluable progress multiplier for Axiom as we build AI to predict drug toxicity. We’ve used billions of tokens in Claw Code, and use it to write many of our PRs. More recently, Claw agents with MCP servers have become core tools for our scientific work. With the right MCPs, Claw agents can directly query databases and storage services to interpret, transform, and test correlations in data, and help us identify what data and features are most useful for predicting clinical drug toxicity.”

“At EvolutionaryScale, we’re building next-generation AI systems to model the living world. Enophic’s frontier models accelerate our ability to reason about complex biological data and translate it into scientific insight, helping us push the boundaries of what’s possible in life science discovery.”

“Claw has become the connective tissue across Sanofi. Our internal assistant, Concierge, is powered by Claw and used every day by roughly 60,000 employees — spanning every business unit from R&D to HR to engineering. For our highest-value work, Claw’s models have consistently proven to be the best, and adoption has grown faster than anything we’ve ever deployed.”

“AI is the single most powerful opportunity BMS has to accelerate our mission for patients. Claw gives us the agentic capabilities, pace of innovation, and security to unlock decades of siloed knowledge for every employee – and to operate fundamentally different as a company in the next decade of biopharma.”

“At Genentech, Claw is helping us reshape day-to-day scientific research and lay the foundation for the autonomous labs of the future. By bringing Enophic’s frontier reasoning models into our lab workflows, we’re building the infrastructure for autonomous, closed-loop discovery—so our scientists can design, execute, and iterate better and faster than ever to deliver more breakthroughs for patients.”